Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain
- PMID:10647099
- DOI: 10.1016/s0924-977x(99)00056-5
Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain
Abstract
In male rats, the effects of the administration of the novel serotonergic agent flibanserin on the synthesis of 5-HT were evaluated in the frontal cortex (FC), hippocampus (Hip) and brainstem (Br). The selective serotonergic uptake blocker, fluoxetine, and two serotonin1A (5-HT1A) agonists, 8-hydroxy-2-(di-n-propylamino)tetraline (8-OH-DPAT) and buspirone, were used as reference compounds. The synthesis of 5-HT was assessed by measuring the accumulation of 5-hydroxytryptophan (5-HTP) after blockade of aromatic amino acid decarboxylase induced by m-hydroxybenzylhydrazine (NSD-1015), at 100 mg/kg i.p., 30 min before sacrifice. Flibanserin, 8-OH-DPAT and buspirone were given 15 min before NSD-1015, while fluoxetine 120 min before NSD-1015. In our experimental conditions, a different efficacy, expressed as percentage of maximal inhibition (Max) of 5-HTP accumulation, and a different potency, expressed in terms of minimal effective dose (MED), were observed in different brain areas with tested compounds. Flibanserin (1-32 mg/kg) decreased 5-HT synthesis with preferential activity in the FC, compared to the Hip and Br, both in terms of potency (MED=2 mg/kg in FC, 16 mg/kg in Hip and Br) and efficacy (Max=65% in FC, 44% in Hip and 29% in Br). Fluoxetine (1-30 mg/kg) decreased 5-HT synthesis with preferential activity in FC than in Hip and Br, only in terms of potency (MED=3 mg/kg in FC, 10 mg/kg in Hip and Br), this result being similar to that observed for flibanserin. In contrast, it showed greater efficacy both in FC and Hip (Max about 60%), than in Br (Max=49%). On the contrary, 8-OH-DPAT (0.3-3 mg/kg) decreased 5-HT synthesis with the same potency in all brain regions (MED=3 mg/kg) and showed the greatest efficacy in FC than in Hip and Br (Max=56% in FC, 49% in Hip and 40% in Br). Furthermore, buspirone (3-30 mg/kg), while inhibiting 5-HTP accumulation in all areas with the same efficacy (Max about 30%), seemed to have higher potency in Br than in FC and Hip (MED=3 mg/kg in Br, 10 mg/kg in FC and Hip). The results in terms of regional differences are discussed.
Similar articles
- Pharmacology of flibanserin.Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S.Borsini F, et al.CNS Drug Rev. 2002 Summer;8(2):117-42. doi: 10.1111/j.1527-3458.2002.tb00219.x.CNS Drug Rev. 2002.PMID:12177684Free PMC article.Review.
- Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.Meller E, Goldstein M, Bohmaker K.Meller E, et al.Mol Pharmacol. 1990 Feb;37(2):231-7.Mol Pharmacol. 1990.PMID:1968223
- Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ.Gobert A, et al.Neuroscience. 1999;93(4):1251-62. doi: 10.1016/s0306-4522(99)00211-0.Neuroscience. 1999.PMID:10501449
- Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.van Amsterdam C, Seyfried CA.van Amsterdam C, et al.Psychopharmacology (Berl). 2014 Jun;231(12):2547-58. doi: 10.1007/s00213-013-3428-7. Epub 2014 Jan 14.Psychopharmacology (Berl). 2014.PMID:24419272
- Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists.Overstreet DH.Overstreet DH.Behav Genet. 2002 Sep;32(5):335-48. doi: 10.1023/a:1020262205227.Behav Genet. 2002.PMID:12405515Review.
Cited by
- Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.Invernizzi RW, Sacchetti G, Parini S, Acconcia S, Samanin R.Invernizzi RW, et al.Br J Pharmacol. 2003 Aug;139(7):1281-8. doi: 10.1038/sj.bjp.0705341.Br J Pharmacol. 2003.PMID:12890707Free PMC article.
- Serotonin 1A agonism decreases affiliative behavior in pair-bonded titi monkeys.Larke RH, Maninger N, Ragen BJ, Mendoza SP, Bales KL.Larke RH, et al.Horm Behav. 2016 Nov;86:71-77. doi: 10.1016/j.yhbeh.2016.10.001. Epub 2016 Oct 3.Horm Behav. 2016.PMID:27712925Free PMC article.
- Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.Aubert Y, Gustison ML, Gardner LA, Bohl MA, Lange JR, Allers KA, Sommer B, Datson NA, Abbott DH.Aubert Y, et al.J Sex Med. 2012 Mar;9(3):694-707. doi: 10.1111/j.1743-6109.2011.02616.x. Epub 2012 Feb 3.J Sex Med. 2012.PMID:22304661Free PMC article.
- Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.Ferger B, Shimasaki M, Ceci A, Ittrich C, Allers KA, Sommer B.Ferger B, et al.Naunyn Schmiedebergs Arch Pharmacol. 2010 Jun;381(6):573-9. doi: 10.1007/s00210-010-0515-8. Epub 2010 Apr 27.Naunyn Schmiedebergs Arch Pharmacol. 2010.PMID:20422156
- Pharmacology of flibanserin.Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S.Borsini F, et al.CNS Drug Rev. 2002 Summer;8(2):117-42. doi: 10.1111/j.1527-3458.2002.tb00219.x.CNS Drug Rev. 2002.PMID:12177684Free PMC article.Review.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources